-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Acorda Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Acorda Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $114K.
- Acorda Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was -$41M, a 245% decline year-over-year.
- Acorda Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was -$43.2M, a 241% decline from 2022.
- Acorda Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $30.7M.
- Acorda Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was -$5.12M, a 36.6% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)